Nile Basin Initiative definition

Nile Basin Initiative or “NBI” means the transitional arrangement established by the Nile Basin States at the meeting of their Council of Ministers held in Dar-es-Salaam, Tanzania, on 22nd February, 1999, to foster cooperation and sustainable development of the Nile River for the benefit of the inhabitants of those countries;
Sample 1Sample 2Sample 3
Nile Basin Initiative and the acronym “NBI” mean the intergovernmental partnership of ten Nile Basin countries based on a vision to achieve sustainable socio-economic development through equitable utilization of, and benefit from, the common Nile Basin water resources.
Sample 1
Nile Basin Initiative or “NBI” means the transitional arrangement established by the Nile Basin States at the meeting of their Council of Ministers held in Dar-es-Salaam, Tanzania, on 22nd February, 1999, to foster cooperation and sustainable development of the Nile River for the benefit of the inhabitants of those countries (NBI Act, 2002). According to the NBI Act (2002), The NBI shall have the capacity, within Uganda, of a body corporate with perpetual succession, and with power to acquire, hold, manage and dispose of movable and immovable corporate property, and to sue and be sued in its own name.
Sample 1

Examples of Nile Basin Initiative in a sentence

  • The Nile Basin Initiative (NBI) is a trans-na- tional cooperative mechanism of ten ripari- an countries.

  • The Nile Basin Initiative (NBI) is a transitional cooperative mechanism of ten riparian countries to realize a jointly articulated Shared Vision: “To achieve sustainable socio- economic development through the equitable utilization and benefit from the common Nile Basin water resources”.

  • The Nile Basin Initiative (NBI) is a partnership of the 10 Nile Basin riparian states with a shared vision objective to promote sustainable socio-economic development through the equitable utilization of and benefit from the shared Nile Basin water resources.

  • The Nile Basin Initiative is currently addressing the issue of equitable utilization of the common Nile Basin water resources.The Nile Basin Initiative seeks to harness the tremendous potential of the Nile for the benefit of the people of the Basin, both for now and for generations to come.

  • The Nile Basin Initiative (NBI) is an inter-governmental organization initiated and led bythe Nile riparian countries to promote joint development, protection and management of the common Nile River Basin water resources.

  • Nile Basin Initiative (NBI) has developed the SEF instead of a comprehensive Stakeholder Engagement Plan (SEP) at this point in time due to the fact that detailed information that would form the basis for developing a comprehensive SEP is still being put together and the available information is yet to be confirmed through on going planning and stakeholder engagement process.

  • The Nile Basin Initiative (NBI) is an inter-governmental organization initiated and led by the Nile riparian countries to promote joint development, protection and management of the common Nile River Basin water resources.Nile Basin Initiative is developing basin wide project under the title “Nile Cooperation for Climate Resilience” focused on trans-boundary cooperative water resources management and development.

  • This necessitates need for striking a delicate balance in facilitating socio-economic development, thus why Nile Basin Initiative in its journey of enabling socio-economic development in Nile Basin region has endeavoured to ensure environmental and social safeguards in its river basin planning and development actions.

  • The Nile Basin Initiative (NBI) is an inter‐governmental organization initiated and led by the Nile riparian countries to promote joint development, protection and management of the common Nile Basin water resources.

  • The Nile Basin Initiative (NBI) is a partnership of the 10 Nile Basin riparian states with a shared vision objective to promote sustainable socio‐economic development through the equitable utilization of and benefit from the shared Nile Basin water resources.


More Definitions of Nile Basin Initiative

Nile Basin Initiative means the institution established pursuant to the NBI Instruments (as hereinafter defined), and invested, on a transitional basis, with legal personality to perform all the functions entrusted to it, or any successor thereto;
Sample 1
Nile Basin Initiative means the framework launched in February 1999 to provide an institutional mechanism, a shared vision, and a set of agreed policy guidelines through which the Riparian States (as hereinafter defined) can cooperatively develop the resources of the Nile Basin to fight poverty and promote socio-economic development in the region.
Sample 1

Related to Nile Basin Initiative

  • Mobile crisis outreach team means a crisis intervention service for minors or families of minors experiencing behavioral health or psychiatric emergencies.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Multiregional Modeling Working Group or “MMWG” shall mean the NERC working group that is charged with multi-regional modeling.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Step therapy means a program for Insureds who take Prescription Drugs for an ongoing medical condition, such as arthritis, asthma or high blood pressure, which ensures the Insured receives the most appropriate and cost-effective drug therapy for their condition. The Step Therapy program requires that before benefits are payable for a high cost Covered Drug that may have initially been prescribed, the Insured try a lower cost first-step Covered Drug. If the prescribing Physician has documented with SHL why the Insured’s condition cannot be stabilized with the first-step Covered Drug, SHL will review a request for Prior Authorization to move the Insured to a second-step drug, and so on, until it is determined by SHL that the prescribed Covered Drug is Medically Necessary and eligible for benefit payment.

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Development Program means the implementation of the development plan.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Marketing program means a program established by order of the director pursuant to this act prescribing rules and regulations governing the marketing for processing, distributing, selling, or handling an agricultural commodity produced in this state or agricultural commodity input during a specified period and

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Step therapy protocol means a protocol or program that establishes the specific

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Trial means any human clinical trial of a Product.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Commercial driver s license" means:

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.